Surridge, Katherine

Publications

Sort by

Co-Author Network

Type II kinase inhibitors that target Parkinson's disease-associated LRRK2. Science advances. 2025 Academic Article GET IT
Type-II kinase inhibitors that target Parkinson's Disease-associated LRRK2. 2025 GET IT
Molecular architecture of the autoinhibited kinesin-1 lambda particle. Science advances. 2022 Academic Article GET IT
Times cited: 16
In situ cryo-electron tomography reveals filamentous actin within the microtubule lumen. The Journal of cell biology. 2020 Academic Article GET IT
Times cited: 25

Sort by

Co-investigator Network

Uncovering the molecular mechanisms of LRRK2 regulation in the inflammatory response awarded by American Cancer Society Principal Investigator 2026 - 2027
Determining Parkinson''s Disease-associated LRRK2''s cellular function using designer small molecules awarded by Parkinson''s Disease Foundation, Inc. Principal Investigator 2025 - 2027